Overview
Eko Health, a digital cardiac health company, has announced that healthcare professionals in the UK can now purchase the CORE 500 Digital Stethoscope, along with the Eko+ membership and accessories, through the company’s website and Amazon UK.
Key Features of the CORE 500 Digital Stethoscope
- Supports both in-person and remote care.
- Includes integrated features such as:
- AI insights
- Audio clarity
- Exam recording
- Waveform visualization
- 3-lead ECG
- Integration with Eko’s mobile application for data capture and sharing.
Eko+ Membership Benefits
The Eko+ membership offers:
- AI-enabled detection of heart murmurs, atrial fibrillation, bradycardia, and tachycardia.
- Guided multipoint auscultation.
- Recording and sharing capabilities.
Company Statement
David Bakey, General Manager of Consumer at Eko Health, stated, “Bringing Eko’s AI-powered technology directly to UK healthcare professionals represents an exciting step forward in expanding access to high-quality digital auscultation tools. With CORE 500, Eko+ and a full range of accessories now available through EkoHealth.com, we’re making it easier than ever for providers to integrate advanced stethoscope technology into their practice.”
Recent Developments
In 2024, Eko Health received FDA 510(k) clearance for its AI-enabled cardiac tool designed for early detection of low ejection fraction, a key indicator of heart failure. The Eko Low Ejection Fraction Tool (ELEFT) allows providers to detect low ejection fraction in just 15 seconds during routine exams.
The ELEFT is part of Eko’s SENSORA Cardiac Early Detection Platform, which includes several FDA-cleared algorithms for identifying atrial fibrillation and structural heart murmurs.
Funding and Research
In 2022, Eko Health received a $2.7 million grant from the National Institutes of Health to develop a machine learning algorithm for detecting and classifying pulmonary hypertension. This grant supports an algorithm that utilizes phonocardiogram (PCG) and ECG data collected by Eko’s stethoscopes.
Additionally, Eko Health obtained FDA 510(k) clearance in 2022 for an algorithm that identifies and characterizes heart murmurs in both adult and pediatric patients. The Eko Murmur Analysis Software employs machine learning to analyze heart sounds, phonocardiograms, and ECG signals to detect various types of murmurs.